Structural properties governing drug-plasma protein binding determined by high-performance liquid chromatography method
View/ Open
Liu_et_al_JPBA.pdf (636.7Kb)
Download
Publication date
2018-02Keyword
Plasma proteinsBinding
HPLC
Retention factors (k)
Linear free energy relationship
Abraham (Absolv) descriptors
Rights
© 2017 Elsevier. Reproduced in accordance with the publisher's self-archiving policy. This manuscript version is made available under the CC-BY-NC-ND 4.0 license.Peer-Reviewed
YesOpen Access status
openAccess
Metadata
Show full item recordAbstract
The high-performance liquid chromatography (HPLC) method employing stationary phases immobilized with plasma proteins was used for this study to investigate the structural properties governing drug-plasma protein binding. A set of 65 compounds with a broad range of structural diversity (in terms of volume, hydrogen-bonding, polarity and electrostatic force) were selected for this purpose. The Abraham linear free energy relationship (LFER) analyses of the retention factors on the immobilized HSA (human serum albumin) and AGP (α1-acid glycoprotein) stationary phases showed that McGowan’s characteristic molecular volume (V), dipolarity/polarizability (S) and hydrogen bond basicity (B) are the three significant molecular descriptors of solutes determining the interaction with immobilized plasma proteins, whereas excess molar refraction (E) is less important and hydrogen bond acidity (A) is not of statistical significance in both systems, for electrically neutral compounds. It was shown that ionised acids, as carboxylate anions, bind very strongly to the immobilized HSA stationary phase and that ionised bases, as cations bind strongly to the AGP stationary phase. This is the first time that the effect of ionised species on plasma protein binding has been determined quantitatively; the increased binding of acids to HSA is due almost entirely to acids in their ionised form.Version
Accepted manuscriptCitation
Kamble S, Loadman P, Abraham MH et al (2018) Structural properties governing drug-plasma protein binding determined by high-performance liquid chromatography method. Journal of Pharmaceutical and Biomedical Analysis. 149: 16-21.Link to Version of Record
https://doi.org/10.1016/j.jpba.2017.10.022Type
Articleae974a485f413a2113503eed53cd6c53
https://doi.org/10.1016/j.jpba.2017.10.022